Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
MTEP
100
CHF
CHF 100.00
In stock
AG-CR1-0022-M0055 mgCHF 100.00
AG-CR1-0022-M02525 mgCHF 400.00
Product Details | |
---|---|
Synonyms | 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine |
Product Type | Chemical |
Properties | |
Formula |
C11H8N2S |
MW | 200.3 |
CAS | 329205-68-7 |
Purity Chemicals | ≥98% (NMR) |
Appearance | Light yellow solid. |
Solubility | Soluble in DMSO, 100% ethanol or methanol. |
Identity | Determined by 1H-NMR. |
InChi Key | NRBNGHCYDWUVLC-UHFFFAOYSA-N |
Smiles | CC1=NC(=CS1)C#CC1=CC=CN=C1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent and selective antagonist for mGluR5 [1, 2].
- 5-fold higher anxiolytic activity than MPEP [3].
- Antidepressant [4].
- Neuroprotective [5].
- Produces antiparkinsonian-like effects in rats [6].
Product References
- 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity: J. Med. Chem. 46 204 (2003)
- Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling: A. Klodzinska, et al.; Neuropharmacology 47, 342 (2004)
- Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP: P.M. Lea IV & A.I. Faden; CNS Drug Rev. 12, 149 (2006)
- Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist: A. Palucha, et al.; Pharmacol. Biochem. Behav. 81, 901 (2005)
- Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors: P.M.t. Lea, et al.; Br. J. Pharmacol. 145, 527 (2005)
- MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats: K. Ossowska, et al.; Neuropharmacology 49, 447 (2005)